Edward Neugeboren's most recent trade in Grace Therapeutics Inc. was a trade of 10,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Grace Therapeutics Inc | Edward Neugeboren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2026 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Grace Therapeutics Inc | Edward Neugeboren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Grace Therapeutics Inc | Neugeboren Edward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2023 | 22,500 | 22,500 | - | - | Stock Options (Right to Buy) |